Non-syndromic autosomal-dominant deafness

Clinical Genetics

Volumn 62, Issue 1, 2002, Pages 1-13

  Petersen, Micheal B ^a  

^a AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

Author keywords

Autosomal dominant; Deafness; Gene mapping; Non syndromic

Indexed keywords

COLLAGEN TYPE 11; CONNEXIN 26; GAP JUNCTION PROTEIN; MYOSIN; MYOSIN IIA;

AUTOSOMAL DOMINANT DISORDER; CHROMOSOMAL LOCALIZATION; CHROMOSOME 11Q; CHROMOSOME 13Q; CHROMOSOME 14Q; CHROMOSOME 1P; CHROMOSOME 22Q; CHROMOSOME 5Q; CHROMOSOME 6P; CHROMOSOME 6Q; CHROMOSOME 9Q; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; EARLY DIAGNOSIS; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCUS; GENE MAPPING; GENE MUTATION; GENETIC HETEROGENEITY; GEOGRAPHIC DISTRIBUTION; HETEROZYGOSITY; HUMAN; LINKAGE ANALYSIS; PERCEPTION DEAFNESS; POPULATION RESEARCH; PRIORITY JOURNAL; SHORT SURVEY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CARRIER PROTEINS; COLLAGEN TYPE XI; CONNEXINS; DEAFNESS; EXTRACELLULAR MATRIX PROTEINS; GENES, DOMINANT; GENETIC HETEROGENEITY; HOMEODOMAIN PROTEINS; HUMANS; KCNQ POTASSIUM CHANNELS; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MYOSINS; POTASSIUM CHANNELS; POTASSIUM CHANNELS, VOLTAGE-GATED; RECEPTORS, ESTROGEN; TRANS-ACTIVATORS; TRANSCRIPTION FACTOR BRN-3C; TRANSCRIPTION FACTORS;

EID: 0036665186     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.2002.620101.x     Document Type: Short Survey

References (127)

1. Morton NE. Genetic epidemiology of hearing impairment. Ann N Y Acad Sci 1991: 630: 16-31.
2. Marazita ML, Ploughman LM, Rawlings B et al. Genetic epidemiological studies of early-onset deafness in the US school-age population. Am J Med Genet 1993: 46: 486-491.
3. Nadol JB. Hearing loss. N Engl J Med 1993: 329: 1092-1102.
4. Gorlin RJ, Toriello HV, Cohen MM. Hereditary Hearing Loss and its Syndromes. Oxford: Oxford University Press, 1995.
5. Petit C. Genes responsible for human hereditary deafness: symphony of a thousand. Nat Genet 1996: 14: 385-391.
6. Resendes BL, Williamson RE, Morton CC. At the speed of sound: gene discovery in the auditory system. Am J Hum Genet 2001: 69: 923-935.
7. Van Camp G, Willems; PJ, Smith RJH. Nonsyndromic hearing impairment: unparalleled heterogeneity. Am J Hum Genet 1997: 60: 758-764.
8. Kalatzis V, Petit C. The fundamental and medical impacts of recent progress in research on hereditary hearing loss. Hum Mol Genet 1998: 7: 1589-1597.
9. Keats BJB, Berlin CI. Genomics and hearing impairment. Genome Res 1999: 9: 7-16.
10. Robertson ND, Morton CC. Beginning of a molecular era in hearing and deafness. Clin Genet 1999: 55: 149-159.
11. Willems PJ. Genetic causes of hearing loss. N Engl J Med 2000: 342: 1101-1109.
12. Steel KP, Kros CJ. A genetic approach to understanding auditory function. Nat Genet 2001: 27: 143-149.
13. Leon PE, Raventos H, Lynch E et al. The gene for an inherited form of deafness maps to chromosome 5q31. Proc Natl Acad Sci USA 1992: 89: 5181-5184.
14. Lynch ED, Lee MK, Morrow JE et al. Nonsyndromic deafness DFNA1 associated with mutation of a human homolog of the drosophila gene diaphanous. Science 1997: 278: 1315-1318.
15. Coucke P, Van Camp G, Djoyodiharjo B et al. Linkage of autosomal dominant hearing loss to the short arm of chromosome 1 in two families. N Engl J Med 1994: 331: 425-431.
16. Kubisch C, Schroeder BC, Friedrich T et al. KCNQ4, a novel potassium channel expressed in sensory outer hair cells, is mutated in dominant deafness. Cell 1999: 96: 437-446.
17. Xia J-H, Liu C-Y, Tang B-S et al. Mutations in the gene encoding gap junction protein α-3 associated with autosomal dominant hearing impairment. Nat Genet 1998: 20: 370-373.
18. Chaib H, Lina-Granade G, Guilford P et al. A gene responsible for a dominant form of neurosensory non-syndromic deafness maps to the NSRD1 recessive deafness gene interval. Hum Mol Genet 1994: 3: 2219-2222.
19. Kelsell DP, Dunlop J, Stevens HP et al. Connexin 26 mutations in hereditary non-syndromic sensorineural deafness. Nature 1997: 387: 80-83.
20. Grifa A, Wagner CA, D'Ambrosio L et al. Mutations in GJB6 cause nonsyndromic autosomal dominant deafness at DFNA3 locus. Nat Genet 1999: 23: 16-18.
21. Chen AH, Ni L, Fukushima K et al. Linkage of a gene for dominant non-syndromic deafness to chromosome 19. Hum Mol Genet 1995: 4: 1073-1076.
22. Van Camp G, Coucke P, Balemans W et al. Localization of a gene for non-syndromic hearing loss (DFNA5) to chromosome 7p15. Hum Mol Genet 1995: 4: 2159-2163.
23. Van Laer L, Huizing EH, Verstreken M et al. Nonsyndromic hearing impairment is associated with a mutation in DFNA5. Nat Genet 1998: 20: 194-197.
24. Lesperance MM, Hall JW, Bess FH et al. A gene for autosomal dominant nonsyndromic hereditary hearing impairment maps to 4p16.3. Hum Mol Genet 1995: 4: 1967-1972.
25. Bespalova IN, Van Camp G, Bom SJH et al. Mutations in the Wolfram syndrome 1 gene (WFS1) are a common cause of low frequency sensorineural hearing loss. Hum Mol Genet 2001: 10: 2501-2508.
26. Fagerheim T, Nilssen O, Raeymaekers P et al. Identification of a new locus for autosomal dominant non-syndromic hearing impairment (DFNA7) in a large Norwegian family. Hum Mol Genet 1996: 5: 1187-1191.
27. Kirschhofer K, Kenyon JB, Hoover DM et al. Autosomal-dominant, prelingual, nonprogressive sensorineural hearing loss: localization of the gene (DFNA8) to chromosome 11q by linkage in an Austrian family. Cytogenet Cell Genet 1998: 82: 126-130.
28. Verhoeven K, Van Laer L, Kirschhofer K et al. Mutations in the human α-tectorin gene cause autosomal dominant non-syndromic hearing impairment. Nat Genet 1998: 19: 60-62.
29. Manolis EN, Yandavi N, Nadol JB Jr, et al. A gene for non-syndromic autosomal dominant progressive postlingual sensorineural hearing loss maps to chromosome 14q12-13. Hum Mol Genet 1996: 5: 1047-1050.
30. Robertson NG, Lu L, Heller S et al. Mutations in a novel cochlear gene cause DFNA9, a human nonsyndromic deafness with vestibular dysfunction. Nat Genet 1998: 20: 299-303.
31. O'Neill ME, Marietta J, Nishimura D et al. A gene for autosomal dominant late-onset progressive non-syndromic hearing loss, DFNA10, maps to chromosome 6. Hum Mol Genet 1996: 5: 853-856.
32. Wayne S, Robertson NG, DeClau F et al. Mutations in the transcriptional activator EYA4 cause late-onset deafness at the DFNA10 locus. Hum Mol Genet 2001: 10: 195-200.
33. Tamagawa Y, Kitamura K, Ishida T et al. A gene for a dominant form of non-syndromic sensorineural deafness (DFNA11) maps within the region containing the DFNB2 recessive deafness gene. Hum Mol Genet 1996: 5: 849-852.
34. Liu X-Z, Walsh J, Tamagawa Y et al. Autosomal dominant non-syndromic deafness caused by a mutation in the myosin VIIA gene. Nat Genet 1997: 17: 268-269.
35. Verhoeven K, Van Camp G, Govaerts PJ et al. A gene for autosomal dominant nonsyndromic hearing loss (DFNA12) maps to chromosome 11q22-24. Am J Hum Genet 1997: 60: 1168-1173.
36. Brown MR, Tomek MS, Van Laer L et al. A novel locus for autosomal dominant nonsyndromic hearing loss, DFNA13, maps to chromosome 6p. Am J Hum Genet 1997: 61: 924-927.
37. McGuirt WT, Prasad SD, Griffith AJ et al. Mutations in COL11A2 cause non-syndromic hearing loss (DFNA13). Nat Genet 1999: 23: 413-419.
38. Van Camp G, Kunst H, Flothmann K et al. A gene for autosomal dominant hearing impairment (DFNA14) maps to a region on chromosome 4p16.3 that does not overlap the DFNA6 locus. J Med Genet 1999: 36: 532-536.
39. Vahava O, Morell R, Lynch ED et al. Mutation in transcription factor POU4F3 associated with inherited progressive hearing loss in humans. Science 1998: 279: 1950-1954.
40. Fukushima K, Kasai N, Ueki Y et al. A gene for fluctuating, progressive autosomal dominant nonsyndromic hearing loss, DFNA16, maps to chromosome 2q23-24.3. Am J Hum Genet 1999: 65: 141-150.
41. Lalwani AK, Luxford WM, Mhatre AN et al. A new locus for nonsyndromic hereditary hearing impairment, DFNA17, maps to chromosome 22 and represents a gene for cochleosaccular degeneration. Am J Hum Genet 1999: 64: 318-323.
42. Lalwani AK, Goldstein JA, Kelley MJ et al. Human nonsyndromic hereditary deafness DFNA17 is due to a mutation in nonmuscle myosin MYH9. Am J Hum Genet 2000: 67: 1121-1128.
43. Boensch D, Scheer P, Neumann C et al. A novel locus for autosomal dominant, non-syndromic hearing impairment (DFNA18) maps to chromosome 3q22 immediately adjacent to the DM2 locus. Eur J Hum Genet 2001: 9: 165-170.
44. Morell RJ, Friderici KH, Wei S et al. A new locus for late-onset, progressive, hereditary hearing loss, DFNA20, maps to 17q25. Genomics 2000: 63: 1-6.
45. Kunst H, Marres H, Huygen P et al. Non-syndromic autosomal dominant progressive non-specific mid-frequency sensorineural hearing impairment with childhood to late adolescence onset (DFNA21). Clin Otolaryngol 2000: 25: 45-54.
46. Melchionda S, Ahituv N, Bisceglia L et al. MY06, the human homologue of the gene responsible for deafness in Snell's waltzer mice, is mutated in autosomal dominant nonsyndromic hearing loss. Am J Hum Genet 2001: 69: 635-640.
47. Salam AA, Hafner FM, Linder TE et al. A novel locus (DFNA23) for prelingual autosomal dominant nonsyndromic hearing loss maps to 14q21-q22 in a Swiss German kindred. Am J Hum Genet 2000: 66: 1984-1988.
48. Hafner FM, Salam AA, Linder TE et al. A novel locus (DFNA24) for prelingual nonprogressive autosomal dominant nonsyndromic hearing loss maps to 4q35-qter in a large Swiss German kindred. Am J Hum Genet 2000: 66: 1437-1442.
49. Greene CC, McMillan PM, Barker SE et al. DFNA25, a novel locus for dominant nonsyndromic hereditary hearing impairment, maps to 12q21-24. Am J Hum Genet 2001: 68: 254-260.
50. Mangino M, Flex E, Capon F et al. Mapping of a new autosomal dominant nonsyndromic hearing loss locus (DFNA30) to chromosome 15q25-26. Eur J Hum Genet 2001: 9: 667-671.
51. Kurima K, Peters LM, Yang Y et al. Dominant and recessive deafness caused by mutations of a novel gene, TMC1, required for cochlear hair-cell function. Nat Genet 2002: 30: 277-284.
52. Young T-L, Ives E, Lynch E et al. Non-syndromic progressive hearing loss DFNA38 is caused by heterozygous missense mutation in the Wolfram syndrome gene WFS1. Hum Mol Genet 2001: 10: 2509-2514.
53. Van Camp G, Coucke PJ, Kunst H et al. Linkage analysis of progressive hearing loss in five extended families maps the DFNA2 gene to a 1.25-Mb region on chromosome 1p. Genomics 1997: 41: 70-74.
54. Coucke PJ, Van Hauwe P, Kelley PM et al. Mutations in the KCNQ4 gene are responsible for autosomal dominant deafness in four DFNA2 families. Hum Mol Genet 1999: 8: 1321-1328.
55. Van Hauwe P, Coucke PJ, Declau F et al. Deafness linked to DFNA2: one locus but how many genes? Nat Genet 1999: 21: 263.
56. Talebizadeh Z, Kelley PM, Askew JW et al. Novel mutation in the KCNQ4 gene in a large kindred with dominant progressive hearing loss. Hum Mutat 1999: 14: 493-501.
57. + channel gene, responsible for autosomal dominant hearing loss, cluster in the channel pore region. Am J Med Genet 2000: 93: 184-187.
58. Akita J, Abe S, Shinkawa H et al. Clinical and genetic features of nonsyndromic autosomal dominant sensorineural hearing loss: KCNQ4 is a gene responsible in Japanese. J Hum Genet 2001: 46: 355-361.
59. Richard G, Smith LE, Bailey RA et al. Mutations in the human connexin gene GJB3 cause erythrokeratodermia variabilis. Nat Genet 1998: 20: 366-369.
60. Lopez-Bigas N, Olive M, Rabionet R et al. Connexin 31 (GJB3) is expressed in the peripheral and auditory nerves and causes neuropathy and hearing impairment. Hum Mol Genet 2001: 10: 947-952.
61. Liu X-Z, Xia XJ, Xu LR et al. Mutations in connexin31 underlie recessive as well as dominant non-syndromic hearing loss. Hum Mol Genet 2000: 9: 63-67.
62. Guilford P, Arab SB, Blanchard S et al. A non-syndromic form of neurosensory, recessive deafness maps to the pericentromeric region of chromosome 13q. Nat Genet 1994: 6: 24-28.
63. Mignon C, Fromaget C, Mattei M-G et al. Assignment of connexin 26 (GJB2) and 46 (GJA3) genes to human chromosome 13q11-q12 and mouse chromosome 14D1-E1 by in situ hybridization. Cytogenet Cell Genet 1996: 72: 185-186.
64. Rabionet R, Gasparini P, Estivill X. Molecular genetics of hearing impairment due to mutations in gap junction genes encoding beta connexins. Hum Mutat 2000: 16: 190-202.
65. Kelsell DPW-L, Houseman MJ. Connexin mutations in skin disease and hearing loss. Am J Hum Genet 2001: 68: 559-568.
66. Kumar NM, Gilula NB. The gap junction communication channel. Cell 1996: 84: 381-388.
67. Holt JR, Corey DP. Ion channel defects in hereditary hearing loss. Neuron 1999: 22: 217-219.
68. Steel KP. The benefits of recycling. Science 1999: 285: 1363-1364.
69. Scott DA, Kraft ML, Stone EM et al. Connexin mutations and hearing loss. Nature 1998: 391: 32.
70. Kelley PM, Harris DJ, Comer BC et al. Novel mutations in the connexin 26 gene (GJB2) that cause autosomal recessive (DFNB1) hearing loss. Am J Hum Genet 1998: 62: 792-799.
71. White TW, Deans MR, Kelsell DP et al. Connexin mutations in deafness. Nature 1998: 394: 630-631.
72. Griffith AJ, Chowdhry AA, Kurima K et al. Autosomal recessive nonsyndromic neurosensory deafness at DFNB1 not associated with the compound-heterozygous GJB2 (connexin 26) genotype M34T/167delT. Am J Hum Genet 2000: 67: 745-749.
73. Houseman MJ, Ellis LA, Pagnamenta A et al. Genetic analysis of the connexin-26 M34T variant: identification of genotype M34T/M34T segregating with mild-moderate non-syndromic sensorineural hearing loss. J Med Genet 2001: 38: 20-25.
74. Denoyelle F, Lina-Granade G, Plauchu H et al. Connexin 26 gene linked to a dominant deafness. Nature 1998: 393: 319-320.
75. Tekin M, Arnos KS, Xia XJ et al. W44C mutation in the connexin 26 gene associated with dominant non-syndromic deafness. Clin Genet 2001: 59: 269-273.
76. Martin PEM, Coleman SL, Casalotti SO et al. Properties of connexin26 gap junctional proteins derived from mutations associated with non-syndromal hereditary deafness. Hum Mol Genet 1999: 8: 2369-2376.
77. Morle L, Bozon M, Alloisio N et al. A novel C202F mutation in the connexin26 gene (GJB2) associated with autosomal dominant isolated hearing loss. J Med Genet 2000: 37: 368-370.
78. Richard G, White TW, Smith LE et al. Functional defects of Cx26 resulting from a heterozygous missense mutation in a family with dominant deaf-mutism and palmoplantar keratoderma. Hum Genet 1998: 103: 393-399.
79. Maestrini E, Korge BP, Ocana-Sierra J et al. A missense mutation in connexin26, D66H, causes mutilating keratoderma with sensorineural deafness (Vohwinkel's syndrome) in three unrelated families. Hum Mol Genet 1999: 8: 1237-1243.
80. Heathcote K, Syrris P, Carter ND et al. A connexin 26 mutation causes a syndrome of sensorineural hearing loss and palmoplantar hyperkeratosis (MIM 148350). J Med Genet 2000: 37: 50-51.
81. Lautermann J, ten Cate W-JF, Altenhoff P et al. Expression of the gap-junction connexins 26 and 30 in the rat cochlea. Cell Tissue Res 1998: 294: 415-420.
82. Kelley PM, Abe S, Askew JW et al. Human connexin 30 (GJB6), a candidate gene for nonsyndromic hearing loss: molecular cloning, tissue-specific expression, and assignment to chromosome 13q12. Genomics 1999: 62: 172-176.
83. Lamartine J, Essenfelder GM, Kibar Z et al. Mutations in GJB6 cause hidrotic ectodermal dysplasia. Nat Genet 2000: 26: 142-144.
84. Estivill X, Fortina P, Surrey S et al. Connexin-26 mutations in sporadic and inherited sensorineural deafness. Lancet 1998: 351: 394-398.
85. Scott DA, Kraft ML, Carmi R et al. Identification of mutations in the connexin 26 gene that cause autosomal recessive nonsyndromic hearing loss. Hum Mutat 1998: 11: 387-394.
86. del Castillo I, Villamar M, Moreno-Pelayo MA et al. A deletion involving the connexin 30 gene in nonsyndromic hearing impairment. N Engl J Med 2002: 346: 243-249.
87. Lerer I, Sagi M, Ben-Neriah Z et al. A deletion mutation in GJB6 cooperating with a GJB2 mutation in trans in nonsyndromic deafness: a novel founder mutation in Ashkenazi Jews. Hum Mutat 2001: 18: 460.
88. Van Laer L, Van Camp G, van Zuijlen D et al. Refined mapping of a gene for autosomal dominant progressive sensorineural hearing loss (DFNA5) to a 2-cM region, and exclusion of a candidate gene that is expressed in the cochlea. Eur J Hum Genet 1997: 5: 397-405.
89. Inoue H, Tanizawa Y, Wasson J et al. A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome) Nat Genet 1998: 20: 143-148.
90. Strom TM, Hortnagel K, Hofmann S et al. Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein. Hum Mol Genet 1998: 7: 2021-2028.
91. Ohata T, Koizumi A, Kayo T et al. Evidence of an increased risk of hearing loss in heterozygous carriers in a Wolfram syndrome family. Hum Genet 1998: 103: 470-474.
92. Takeda K, Inoue H, Tanizawa Y et al. WFS1 (Wolfram syndrome 1) gene product: predominant subcellular localization to endoplasmic reticulum in cultured cells and neuronal expression in rat brain. Hum Mol Genet 2001: 10: 477-484.
93. Hughes DC, Legan PK, Steel KP et al. Mapping of the α-tectorin gene (TECTA) to mouse chromosome 9 and human chromosome 11: a candidate for human autosomal dominant nonsyndromic deafness. Genomics 1998: 48: 46-51.
94. Alloisio N, Morle L, Bozon M et al. Mutation in the zon-adhesin-like domain of α-tectorin associated with autosomal dominant non-syndromic hearing loss. Eur J Hum Genet 1999: 7: 255-258.
95. Balciuniene J, Dahl N, Borg E et al. Evidence for digenic inheritance of nonsyndromic hereditary hearing loss in a Swedish family. Am J Hum Genet 1998: 63: 786-793.
96. Balciuniene J, Dahl N, Jalonen P et al. Alpha-tectorin involvement in hearing disabilities: one gene - two phenotypes. Hum Genet 1999: 105: 211-216.
97. Mustapha M, Weil D, Chardenoux S et al. An α-tectorin gene defect causes a newly identified autosomal recessive form of sensorineural pre-lingual non-syndromic deafness, DFNB21. Hum Mol Genet 1999: 8: 409-412.
98. Robertson NG, Skvorak AB, Yin Y et al. Mapping and characterization of a novel cochlear gene in human and in mouse: a positional candidate gene for a deafness disorder, DFNA9. Genomics 1997: 46: 345-354.
99. de Kok YJM, Bom SJH, Brunt TM et al. A Pro51Ser mutation in the COCH gene is associated with late onset autosomal dominant progressive sensorineural hearing loss with vestibular defects. Hum Mol Genet 1999: 8: 361-366.
100. Fransen E, Verstreken M, Verhagen WIM et al. High prevalence of symptoms of Ménière's disease in three families with a mutation in the COCH gene. Hum Mol Genet 1999: 8: 1425-1429.
101. Fransen E, Verstreken M, Bom SJH et al. A common ancestor for COCH related cochleovestibular (DFNA9) patients in Belgium and the Netherlands bearing the P51S mutation. J Med Genet 2001: 38: 61-64.
102. Kamarinos M, McGill J, Lynch M et al. Identification of a novel COCH mutation, I109N, highlights the similar clinical features observed in DFNA9 families. Hum Mutat 2001: 17: 351.
103. Robertson NG, Resendes BL, Lin JS et al. Inner ear localization of mRNA and protein products of COCH, mutated in the sensorineural deafness and vestibular disorder, DFNA9. Hum Mol Genet 2001: 10: 2493-2500.
104. Verhoeven K, Fagerheim T, Prasad S et al. Refined localization and two additional linked families for the DFNA10 locus for nonsyndromic hearing impairment. Hum Genet 2000: 107: 7-11.
105. Borsani G, DeGrandi A, Ballabio A et al. EYA4, a novel vertebrate gene related to Drosophila eyes absent. Hum Mol Genet 1999: 8: 11-23.
106. Abdelhak S, Kalatzis V, Heilig R et al. A human homologue of the Drosophila eyes absent gene underlies Branchio-Oto-Renal (BOR) syndrome and identifies a novel gene family. Nat Genet 1997: 15: 157-164.
107. Abdelhak S, Kalatzis V, Heilig R et al. Clustering of mutations responsible for branchio-oto-renal (BOR) syndrome in the eyes absent homologous region (eyaHR) of EYA1. Hum Mol Genet 1997: 6: 2247-2255.
108. Guilford P, Ayadi H, Blanchard S et al. A human gene responsible for neurosensory, non-syndromic recessive deafness is a candidate homologue of the mouse sh-1 gene. Hum Mol Genet 1994: 3: 989-993.
109. Weil D, Blanchard S, Kaplan J et al. Defective myosin VIIA gene responsible for Usher syndrome type 1B. Nature 1995: 374: 60-61.
110. Gibson F, Walsh J, Mburu P et al. A type VII myosin encoded by the mouse deafness gene shaker-1. Nature 1995: 374: 62-64.
111. Liu X-Z, Walsh J, Mburu P et al. Mutations in the myosin VIIA gene cause nonsyndromic recessive deafness. Nat Genet 1997: 16: 188-190.
112. Weil D, Kussel P, Blanchard S et al. The autosomal recessive isolated deafness, DFNB2, and the Usher 1B syndrome are allelic defects of the myosin-VIIA gene. Nat Genet 1997: 16: 191-193.
113. Weil D, Levy G, Sahly I et al. Human myosin VIIA responsible for the Usher 1B syndrome: a predicted membrane-associated motor protein expressed in developing sensory epithelia. Proc Natl Acad Sci USA 1996: 93: 3232-3237.
114. Janecke AR, Meins M, Sadeghi M et al. Twelve novel myosin VIIA mutations in 34 patients with Usher syndrome type I: confirmation of genetic heterogeneity. Hum Mutat 1999: 13: 133-140.
115. Vikkula M, Mariman EC, Lui VC et al. Autosomal dominant and recessive osteochondrodysplasias associated with the COL11A2 locus. Cell 1995: 80: 431-437.
116. Erkman L, McEvilly RJ, Luo L et al. Role of transcription factors Brn-3.1 and Brn-3.2 in auditory and visual system development. Nature 1996: 381: 603-606.
117. de Kok YJM, van der Maarel SM, Bitner-Glindzicz M et al. Association between X-linked mixed deafness and mutations in the POU domain gene POU3F4. Science 1995: 267: 685-688.
118. The May-Hegglin/Fechtner Syndrome Consortium. Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. Nat Genet 2000: 26: 103-105.
119. Kelley MJ, Jawien W, Ortel TL et al. Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly. Nat Genet 2000: 26: 106-108.
120. Heath KE, Campos-Barros A, Toren A et al. Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes. Am J Hum Genet 2001: 69: 1033-1045.
121. Avraham KB, Hasson T, Steel KP et al. The mouse Snell's waltzer deafness gene encodes an unconventional myosin required for structural integrity of inner ear hair cells. Nat Genet 1995: 11: 369-375.
122. Wang A, Liang Y, Fridell RA et al. Association of unconventional myosin MYO15 mutations with human non-syndromic deafness DFNB3. Science 1998: 280: 1447-1451.
123. Avraham KB, Hasson T, Sobe T et al. Characterization of unconventional MYO6, the human homologue of the gene responsible for deafness in Snell's waltzer mice. Hum Mol Genet 1997: 6: 1225-1231.
124. Ahituv N, Sobe T, Robertson NG et al. Genomic structure of the human unconventional myosin VI gene. Gene 2000: 261: 269-275.
125. Jain PK, Fukushima K, Deshmukh D et al. A human recessive neurosensory non-syndromic hearing impairment locus is a potential homologue of the murine deafness (dn) locus. Hum Mol Genet 1995: 4: 2391-2394.
126. Scott DA, Carmi R, Elbedour K et al. An autosomal recessive nonsyndromic-hearing-loss locus identified by DNA pooling using two inbred Bedouin kindreds. Am J Hum Genet 1996: 59: 385-391.
127. Vreugde S, Erven A, Kros CJ et al. Beethoven, a mouse model for dominant, progressive hearing loss DFNA36. Nat Genet 2002: 30: 257-258.